Sign in
WithdrawnNo phase

Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients

Key facts

Who runs it
Brigham and Women's Hospital
Where
Boston, United StatesSee the site
Trial code
Status
Withdrawn
Started
30 Mar 2024
Ended
28 Feb 2025
Type of study
Observational
Treatments tested
  • Transoral Incisionless Fundoplication
Record updated
5 August 2024
Why it stopped
Sponsor decided not to fund the study.

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • Any adult with a confirmed diagnosis of LPR with HEMII-pH (≥2 LPR events in 24 hr period), Esophageal manometry and Laryngoscopy
  • Having daily bothersome symptoms of LPR
  • Willing and able to cognitively sign a consent form for Surgical treatment of LPR with the TIF
  • Willing and available for follow up visit and repeat testing (HEMII-pH, Esophageal manometry and laryngoscopy) at 3 months post procedure

Who cannot take part

  • Enrollment in another device or drug study that may confound the results
  • Esophageal ulcer
  • Portal hypertension and/or varices
  • Active gastro-duodenal ulcer disease; Gastric outlet obstruction or stenosis
  • Coagulation disorders
  • History of any of the following: resective gastric or esophageal surgery, anti-reflux surgery with anatomy unsuitable for TIF procedure per physician judgment, cervical spine fusion, Zenker's diverticulum, esophageal epiphrenic diverticulum, achalasia, scleroderma or dermatomyositis, eosinophilic esophagitis, or cirrhosis
  • Acute or chronic illness or history of illness which in the opinion of the investigator could pose a threat or harm to the subject or obscure interpretation of laboratory test results or interpretation of study data, such as frequent angina, Class III or IV congestive heart failure, moderate impairment of renal or hepatic function, poorly controlled diabetes (HbA1c >12%), etc
  • Any clinically significant abnormalities on physical examination or laboratory abnormalities identified in the medical record, as determined by the investigator
  • Unable or unwilling to provide informed consent
  • Unable or unwilling to comply with study procedures
  • Body Mass Index >35
  • Hiatal hernia>2cm in axial height and >2cm in greatest transverse dimension
  • Esophagitis grade C and D
  • Barrett's esophagus>2cm
  • Fixed esophageal stricture or narrowing
  • Gastroparesis
  • Pregnancy or plans of pregnancy in the next 12 months

Where in United States

  • Brigham and Women's HospitalBoston, United States

About the trial

What the trial wants to find out

In this research study the investigators want to learn more about the effectiveness of an endoscopic procedure (an endoscope is a lighted tube that is placed down the participants esophagus, through the participants mouth) which uses a device that allows the doctor to repair or recreate the body's natural barrier to reflux. It uses preloaded forceps (tweezers) and fasteners and requires no incision to tighten the connection between the participants esophagus and stomach. This procedure is performed to aid in the treatment of symptoms of Gastroesophageal Reflux disease (GERD) in patients with diagnosed Laryngopharyngeal reflux (LPR). LPR is a condition resulting from backflow of stomach contents into the laryngopharynx (connection point in the participants throat through which food, water, and air pass) resulting in symptoms that can be referred to larynx/hypopharynx. The device the investigators will use to perform the transoral incisionless fundoplication procedure (TIF) is called the EsophyX device. The participants have been asked to participate because they have been diagnosed with LPR and have either failed medical therapy (taking prescription proton pump inhibitors (PPI) to reduce stomach acid production or do not want to be on long-term medical treatment.

The group in the trial

  • LPR Patients

    Adults with a confirmed diagnosis of LPR with HEMII-pH (≥2 LPR events in 24 hr period), Esophageal manometry and Laryngoscopy undergoing endoscopic transoral incisionless fundoplication (TIF).

    Treatment: Transoral Incisionless Fundoplication

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
5 August 2024